The Founder, Chairman, and Chief Executive Officer (CEO) of Concordance, Danny Ludeman, shared a personal health update with the Board of Directors on May 14, 2024. He has been diagnosed with early-stage pancreatic cancer and has begun a treatment plan in coordination with his medical team at Johns Hopkins. To prioritize his health at this time, Danny will transition to the role of Executive Chairman effective immediately, and current President and Chief Operating Officer (COO), Michelle Smith, will assume the role of CEO. The transition follows a decade of collaboration between the Danny and Michelle and is simply an acceleration of their original succession plan. Danny and his medical team are optimistic about his prognosis and expresses full confidence in Michelle’s leadership to continue the Concordance mission. For media inquiries, please contact Jordan.Lubowitz@ogilvy.com.
Recent Stories
Susan Stith Appointed CEO to Lead Concordance into Next Phase of Growth and Impact
Concordance, a non-profit organization dedicated to transforming lives by reducing the rates of reincarceration, today announced the appointment of Susan Stith as Chief Executive Officer. Stith, a Concordance Board member who has been serving as Interim CEO since August 2024, will lead the organization in its next phase of growth and impact.
Statement from David L. Steward, Board Chair, Concordance and Susan Stith, Interim CEO, Concordance
We are saddened to learn of the passing of our founder and former Chairman, Danny Ludeman, after a courageous battle with pancreatic cancer.
Concordance Begins National Search For New CEO
Susan Stith Named Interim CEO.
Concordance Begins Operations in South Carolina.